LivaNova Initiates Study for VNS Therapy in Heart Failure Patients
Summary
LivaNova announced the initiation of a clinical study evaluating vagus nerve stimulation therapy for patients with heart failure. The study will assess whether VNS can improve heart function and reduce symptoms by modulating the autonomic nervous system. The rationale is based on the role of the vagus nerve in regulating cardiac function and the inflammatory response.
Why it matters
Heart failure represents a potential new indication for vagus nerve stimulation, expanding the therapeutic applications of neuromodulation beyond neurological conditions. If successful, this could open a very large patient population for VNS therapy. The study also reflects growing interest in bioelectronic medicine approaches that use electrical stimulation to treat conditions traditionally managed with pharmaceuticals.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial